Corcept therapeutics inc (CORT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Product revenue, net

93,247

87,895

81,505

72,257

64,829

66,831

64,445

62,312

57,659

53,280

42,763

35,559

27,599

23,811

21,725

19,724

16,061

14,967

13,261

11,956

10,102

9,013

7,282

5,851

4,405

4,115

2,634

1,891

1,717

1,377

1,055

875

0

-

-

-

-

-

-

Operating expenses:
Cost of sales

1,878

1,436

1,451

1,377

1,240

1,579

1,308

1,154

1,174

1,157

976

775

646

561

668

426

403

364

256

439

302

258

235

215

174

60

40

23

20

19

24

48

0

-

-

-

-

-

-

Research and development

26,123

24,312

22,805

21,656

20,244

18,794

18,860

20,543

17,050

13,631

11,693

7,876

7,176

6,484

7,054

5,672

4,634

4,089

3,612

3,341

4,377

3,788

3,047

4,252

7,285

6,567

5,155

4,491

4,257

4,856

3,008

2,668

3,542

6,646

3,228

6,203

4,924

5,224

4,574

Selling, general and administrative

27,535

27,134

24,245

24,591

24,389

21,560

21,308

19,981

18,440

16,795

16,471

14,113

15,037

11,759

10,931

12,118

10,432

8,863

9,291

9,342

9,453

8,043

9,103

7,965

9,805

7,518

7,179

8,160

8,383

6,482

5,694

5,751

7,487

3,282

3,209

2,666

2,174

1,881

1,871

Total operating expenses

55,536

52,882

48,501

47,624

45,873

41,933

41,476

41,678

36,664

31,583

29,140

22,764

22,859

18,804

18,653

18,216

15,469

13,316

13,159

13,122

14,132

12,089

12,385

12,432

17,264

14,145

12,374

12,674

12,660

11,357

8,726

8,467

11,029

9,928

6,437

8,869

7,098

7,105

6,445

Income from operations

37,711

35,013

33,004

24,633

18,956

24,898

22,969

20,634

20,995

21,697

13,623

12,795

4,740

5,007

3,072

1,508

592

1,651

102

-1,166

-4,030

-3,076

-5,103

-6,581

-12,859

-10,030

-9,740

-10,783

-10,943

-9,980

-7,671

-7,592

-11,029

-9,928

-6,437

-8,869

-7,098

-7,105

-6,445

Interest and other income

1,471

1,447

1,348

1,178

1,097

1,042

759

562

294

188

86

-98

-225

-2,694

-487

531

611

-5,238

703

770

800

819

903

971

1,071

1,094

1,166

1,114

1,141

1,144

622

5

5

7

1

12

5

3

3

Interest and other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

3

-1

2

4

753

Income before income taxes

39,182

36,460

34,352

25,811

20,053

25,940

23,728

21,196

21,289

21,885

13,709

12,697

4,515

4,597

2,585

977

-19

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

9,100

7,095

8,000

5,600

1,800

3,913

6,000

3,000

3,830

-76,445

-48

50

127

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income

30,065

29,381

26,340

20,186

18,274

22,008

17,747

18,196

17,459

98,330

13,757

12,647

4,388

4,597

2,585

977

-19

959

-601

-1,936

-4,830

-3,895

-6,006

-7,552

-13,930

-11,124

-10,906

-11,897

-12,084

-11,124

-8,293

-7,597

-11,034

-9,936

-6,435

-8,882

-7,101

-7,104

-5,695

Other comprehensive income (loss):
Net unrealized gain on available-for-sale investments, net of tax impact of $(20) and $(52), respectively

61

-62

-2

227

164

82

50

25

-152

-61

3

-5

-12

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency translation loss, net of tax

-12

-

-5

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total comprehensive income

30,114

29,328

26,333

20,413

18,438

22,090

17,797

18,221

17,307

98,269

13,760

12,642

4,376

4,597

2,585

977

-19

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic net income per share (in dollars per share)

0.26

0.25

0.23

0.18

0.16

0.19

0.15

0.16

0.15

0.87

0.12

0.11

0.04

-

0.02

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net income per share (in dollars per share)

0.25

0.23

0.22

0.17

0.15

0.18

0.14

0.14

0.14

0.79

0.11

0.10

0.04

-

0.02

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net income (loss) per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-0.01

-0.02

-0.05

-0.04

-0.06

-0.07

-0.14

-0.11

-0.11

-0.12

-0.12

-0.11

-0.08

-0.09

-0.13

-0.11

-0.08

-0.11

-0.09

-0.10

-0.09

Weighted-average shares outstanding used in computing net income per share
Basic (in shares)

114,575

114,337

113,875

114,340

114,844

115,200

115,798

115,492

114,882

114,389

113,603

113,249

112,867

111,917

110,652

110,034

109,661

-

108,461

107,874

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in shares)

122,226

122,824

121,762

121,783

123,895

125,345

126,159

127,515

127,733

128,209

125,651

123,011

121,189

123,147

116,419

115,329

109,661

-

108,461

107,874

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding used in computing basic and diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

101,905

-

101,134

100,980

100,521

99,834

99,814

99,814

99,814

99,937

99,082

88,621

84,420

84,274

84,188

84,010

80,764

72,045

66,142